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422this possibility, in the VALUE study, we evaluated the
effect of baseline HR on incident HF occurring sepa-
rately in each year of the trial (2). If tachycardia were a
marker of subclinical congestive HF, a stronger asso-
ciation would be expected in the early phases of the
follow-up with an attenuation in later years. However,
the association between high HR and incident HF was
present throughout the trial and was signiﬁcant even
at the ﬁfth year.
To see whether this ﬁnding obtained in a hyper-
tensive sample also holds true within a general pop-
ulation, we encourage the MESA investigators to
analyze the predictive power of baseline HR by using
the same statistical procedure.*Paolo Palatini, MD
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15:3–17.REPLY: Resting Heart Rate: An Independent
Predictor of Congestive Heart FailureWe thank Drs. Palatini and Julius for their interest in
our recent work (1). Indeed, in the MESA (Multi-Ethnic
Study of Atherosclerosis) study, with participants
without cardiovascular disease (CV) at enrollment, we
found an increased risk for incident heart failure (HF)
among those with elevated resting heart rate (HR).
We appreciate that in the VALUE (Valsartan Antihy-
pertensive Long-term Use Evaluation) trial extensive
analyses of resting HR and incident HF were made in a
large sample of hypertensive patients with high car-
diovascular risk on antihypertensive treatment (2).
Unfortunately, in-trial HR measurements were not a
part of our study (1).
We agree that a possible relationship between HR
and coronary events may have been unrecognized in
our study due to power issues. On the other hand, thisdoes not prove the existence of such a relationship in a
population without clinical CV diseases at enrollment,
and alternative mechanisms may also contribute or
coexist. Moreover, in our study, the resting HRs were
somewhat lower than in the hypertensive patients
in the VALUE trial, probably reﬂecting a healthier
population.
Using a statistical procedure similar to that in the
VALUE trial, we evaluated the effect of baseline HR
on HF events occurring separately for each 2-year
interval of follow-up. In this post hoc analysis, a sig-
niﬁcant association was found between resting HR
and HF events occurring during the ﬁrst 2-year
follow-up interval. In a multivariate Cox model, the
hazard ratio (HR) for the highest baseline HR quartile
(HR >70 beats/min) was 2.37 (95% conﬁdence inter-
val: 1.13 to 5.01) compared to the 3 lower quartiles
(HR <70 beats/min). However, no signiﬁcant associ-
ations were found between HR and HF events
occurring after the ﬁrst 2 years. Thus, in contrast to
the hypertensive sample in the VALUE study, in our
study population without CV disease at baseline, one
cannot exclude the possible relationship between
latent left ventricular dysfunction and elevated HF.
More studies of the relationship between resting HR
and CV disease are certainly needed and we thank
you for your valuable contributions to this ﬁeld.Anders Opdahl, MD, PhD
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